Carrier frequency of SMN1‐related spinal muscular atrophy in north Indian population: The need for population based screening program

• Published in: American journal of medical genetics. Part A Vol. 185; no. 1; pp. 274 - 277
• Main Authors: Nilay, Mayank, Moirangthem, Amita, Saxena, Deepti, Mandal, Kausik, Phadke, Shubha R.
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.01.2021; Wiley Subscription Services, Inc
• Subjects: Catchment areas; Chromosome 5; Exons; Gene deletion; Hereditary diseases; Infant mortality; Neuromuscular diseases; SMN protein; Spinal muscular atrophy
• DOI: 10.1002/ajmg.a.61918
• ISSN: 1552-4825; 1552-4833

Chromosome 5q related Spinal muscular atrophy (SMA) is an autosomal recessive, progressive, neuromuscular disorder most commonly caused by homozygous deletion of exon 7 or exon 7 and 8 of SMN1 gene. Being the leading genetic cause of infant mortality, studies of its prevalence and incidence are necessary. Carrier testing for the common pathogenic variant for SMA is offered to the couples visiting our tertiary care hospital in North India. Subjects were tested for SMA carrier status by Multiplex Ligation‐dependent Probe amplification (MLPA) technique for deletion of exons 7 and 8 of SMN1 gene. The retrospective data of individuals tested for SMA carrier status in last 4 years (2016–2019) was evaluated. Six hundred and six individuals without family history of SMA or carrier of SMA who were subjected to MLPA based screening for SMA carrier status were included in the study. The carrier frequency of SMN1 deletion (deletion of exon 7 and/or exon 8) was found to be 1 in 38 (16 out of 606). The catchment area of our medical genetics clinic covering the state of Uttar Pradesh (16.5% of Indian population according to censusindia.gov.in, 2011) and neighboring states, showing SMA carrier frequency of 1:38 in a cohort with no prior positive family history has important significance for policy making.